Canagliflozin, a sodium glucose co-transporter 2 inhibitor, for the management of type 2 diabetes.
about
What's next after metformin? focus on sulphonylurea: add-on or combination therapyCanagliflozin as an Initial Therapy in Drug-Naïve Subjects with Type 2 Diabetes Mellitus: A Potential Involvement of Atherogenic Lipids in its Glycemic Efficacy.Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus.Characterization of Metabolic Parameters in Responders and Nonresponders Treated with Canagliflozin Monotherapy in Drug-naive Subjects with Type 2 Diabetes.
P2860
Canagliflozin, a sodium glucose co-transporter 2 inhibitor, for the management of type 2 diabetes.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Canagliflozin, a sodium glucos ...... management of type 2 diabetes.
@en
type
label
Canagliflozin, a sodium glucos ...... management of type 2 diabetes.
@en
prefLabel
Canagliflozin, a sodium glucos ...... management of type 2 diabetes.
@en
P2860
P356
P1433
P1476
Canagliflozin, a sodium glucos ...... management of type 2 diabetes.
@en
P2093
Stephen Brunton
Timothy S Reid
P2860
P304
P356
10.3810/HP.2014.08.1122
P407
P577
2014-08-01T00:00:00Z